FTH Insider Trading Activity and SEC Form 4 Filings
FTH insider trading summary
Over the past 12 months, insiders at Faeth Therapeutics, Inc. (FTH) reported 23 open-market purchases worth $1.2M by 2 insiders and no sales on SEC Form 4. Net insider buying was $1.2M.
Latest FTH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $15K (600 @ $24.22) |
| Jul 1, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $103K (4,400 @ $23.40) |
| Jun 30, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $44K (1,910 @ $22.95) |
| Jun 30, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $106K (4,255 @ $24.98) |
| Jun 30, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $39K (1,638 @ $23.88) |
| Jun 29, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $19K (831 @ $23.34) |
| Jun 26, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $105K (4,212 @ $24.90) |
| Jun 26, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $14K (580 @ $23.61) |
| Jun 26, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $3K (100 @ $26.39) |
| Jun 26, 2026 | Brian C Stephenson | Chief Financial Officer | Buy | $35K (1,358 @ $25.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.